VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors
University of Texas Southwestern Medical Center
University of Texas Southwestern Medical Center
Deciphera Pharmaceuticals, LLC
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Peking University People's Hospital
Kivu Bioscience Inc.
Amgen
New York Medical College
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Instituto do Cancer do Estado de São Paulo
EMD Serono
Children's Hospital of Philadelphia
Case Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
Institut Claudius Regaud
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Verismo Therapeutics
Fundación de investigación HM
Rezolute
Thomas Jefferson University
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Stanford University
Merck Sharp & Dohme LLC
Milton S. Hershey Medical Center
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Ascentage Pharma Group Inc.
Fred Hutchinson Cancer Center
Parabilis Medicines, Inc.
Milton S. Hershey Medical Center
University College, London
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Duke University
Second Affiliated Hospital, School of Medicine, Zhejiang University
National Institutes of Health Clinical Center (CC)
Bayer
Second Affiliated Hospital, School of Medicine, Zhejiang University
Mayo Clinic
Memorial Sloan Kettering Cancer Center